426219-53-6 Usage
Uses
Used in Oncology:
TAK-700 is used as a therapeutic agent for hormone-sensitive cancers, primarily targeting prostate cancer. It works by inhibiting the enzyme 17,20-lyase, thereby reducing the levels of androgens that fuel tumor growth.
Used in Prostate Cancer Treatment:
In the field of prostate cancer treatment, TAK-700 is utilized as an androgen synthesis inhibitor to slow down the progression of the disease by limiting the availability of androgens that promote tumor growth.
Used in Breast Cancer Research:
TAK-700 has also been explored in the context of breast cancer treatment, where it has demonstrated potential benefits in early clinical trials. Its use in this area is aimed at further investigation to understand its full therapeutic potential and safety profile.
Check Digit Verification of cas no
The CAS Registry Mumber 426219-53-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,6,2,1 and 9 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 426219-53:
(8*4)+(7*2)+(6*6)+(5*2)+(4*1)+(3*9)+(2*5)+(1*3)=136
136 % 10 = 6
So 426219-53-6 is a valid CAS Registry Number.
426219-53-6Relevant articles and documents
1,1-Diarylalkenes as anticancer agents: Dual inhibitors of tubulin polymerization and phosphodiesterase 4
Ruchelman, Alexander L.,Man, Hon-Wah,Chen, Roger,Liu, Wei,Lu, Ling,Cedzik, Dorota,Zhang, Ling,Leisten, Jim,Collette, Alice,Narla, Rama Krishna,Raymon, Heather K.,Muller, George W.
, p. 6356 - 6374 (2011)
A series of 1,1-diarylalkene derivatives were prepared to optimize the properties of CC-5079 (1), a dual inhibitor of tubulin polymerization and phosphodiesterase 4 (PDE4). By using the 3-ethoxy-4-methoxyphenyl PDE4 pharmacophore as one of the aromatic ri